-+ 0.00%
-+ 0.00%
-+ 0.00%

Trevi Therapeutics closes USD 173 million follow-on stock offering at USD 13 per share

PUBT·04/20/2026 20:05:44
Listen to the news
Trevi Therapeutics closes USD 173 million follow-on stock offering at USD 13 per share
  • Trevi Therapeutics closed underwritten public offering of 13,340,000 common shares at USD 13 per share.
  • Gross proceeds were about USD 173 million before underwriting discounts, commissions, and offering expenses.
  • Underwriters exercised option in full to buy 1,740,000 additional shares.
  • All shares in offering were sold by Trevi.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trevi Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604201605PRIMZONEFULLFEED9693311) on April 20, 2026, and is solely responsible for the information contained therein.